Journal article
Association between glutathione S-transferase pi genetic polymorphisms and oral cancer risk
Pharmacogenetics (London), Vol.9(4), pp.497-504
08/1999
Handle:
https://hdl.handle.net/2376/109256
PMID: 10780269
Abstract
Polymorphisms in the gene encoding the glutathione S-transferase (GST) pi metabolizing enzyme have previously been associated with susceptibility to various cancers. In this study, the importance of GSTP1 genotypes as determinants of risk for oral cancer was assessed by examining the prevalence of GSTP1 alleles in 157 incident oral cancer cases and 260 non-cancer control individuals frequency-matched by race, sex, and age at diagnosis (+/- 5 years). The GSTP1*A, GSTP1*B, GSTP1*C, and GSTP1*D alleles were elucidated by polymerase chain reaction-restriction fragment length polymorphism analysis of polymorphisms present in codons 105 (isoleucine:valine) and 114 (alanine:valine) of the GSTP1 gene. Increased risk for oral cancer was observed in individuals who were homozygous for any combination of GSTP1 polymorphic alleles (i.e. *B, *C, and/or *D alleles; odds ratio = 2.4, 95% confidence interval = 1.2-4.8). Similar risk was observed in both Caucasians (odds ratio = 2.6, 95% confidence interval = 1.1-6.2) and African-Americans (odds ratio = 2.3, 95% CI = 0.68-7.5). A greater risk was observed in individuals with the GSTP1 (Var/Var) genotype who were exposed to low levels of smoking (i.e. < or = 20 pack-years [py], odds ratio = 3.4, 95% confidence interval = 1.1-11) than among heavier smokers (i.e. > 20 pack-years [py], odds ratio = 1.4, 95% confidence interval = 0.48-4.0). These results suggest that GSTP1 genotype may play a role in risk for oral cancer particularly among lighter smokers.
Metrics
10 Record Views
Details
- Title
- Association between glutathione S-transferase pi genetic polymorphisms and oral cancer risk
- Creators
- J Y Park - Department of Pathology, Temple University School of Medicine, Philadelphia, PA 19140, USAS P SchantzJ C SternT KaurP Lazarus
- Publication Details
- Pharmacogenetics (London), Vol.9(4), pp.497-504
- Academic Unit
- Pharmaceutical Sciences, Department of
- Publisher
- England
- Grant note
- F32 CA073173 / NCI NIH HHS CA59917 / NCI NIH HHS CA73173 / NCI NIH HHS R01 CA059917 / NCI NIH HHS DE12206 / NIDCR NIH HHS
- Identifiers
- 99900547018801842
- Language
- English
- Resource Type
- Journal article